Kempharm Stock Today

It looks like this equity (KMPHD) cannot be resolved or is no longer available, but we have found another equity that may match the characteristics of what you are looking for. Please check KMPH Kempharm to make sure you are using current equity.
Kempharm cannot be verified against its exchange. Apparently, Kempharm is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Kempharm Stock Profile

KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs in the United States. The company was founded in 2006 and is headquartered in Celebration, Florida. Kempharm operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 22 people.. The public information regarding Kempharm's current market price is not available at this time.
Kempharm is now traded under the symbol KMPH. Please update your portfolios or report it if you believe this is an error. Report It!
Legal NameKempharm
New SymbolKMPH
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Kempharm's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
Kempharm (KMPHD) is traded on NASDAQ Exchange in USA and employs 22 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 56.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kempharm's market, we take the total number of its shares issued and multiply it by Kempharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Kempharm classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 4.53 M outstanding shares of which 44.43 K shares are now shorted by private and institutional investors with about 0.2 days to cover all short positions. Kempharm has accumulated about 5.27 M in cash with (3.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16.
Check Kempharm Probability Of Bankruptcy

Kempharm Stock Against Markets

Picking the right benchmark for Kempharm stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Kempharm stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Kempharm is critical whether you are bullish or bearish towards Kempharm at a given time.
Kempharm cannot be verified against its exchange. Apparently, Kempharm is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

Delisting Warning - KMPHD

Kempharm was delisted

  The entity Kempharm with a symbol KMPHD was delisted from NASDAQ Exchange. Please use Kempharm with a symbol KMPH from now on.
Check out Stocks Correlation. Note that the Kempharm information on this page should be used as a complementary analysis to other Kempharm's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Other Tools for Kempharm Stock

When running Kempharm price analysis, check to measure Kempharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kempharm is operating at the current time. Most of Kempharm's value examination focuses on studying past and present price action to predict the probability of Kempharm's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kempharm's price. Additionally, you may evaluate how the addition of Kempharm to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go